Emerging evidences suggested that PRKCE plays oncogenic role through increasing survival protein levels, which sustained cancer stem cell development.17 Our study reinforced the oncogenic role of PRKCE in increasing gemcitabine resistance and its correlation with a poor prognosis in GBC tumors. The gene discussed is PRKCE; the disease is cancer.